Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial
S M Blaney, N L Seibel, M O'Brien, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2010
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates
P A Baxter, P A Thompson, L M McGuffey, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2004
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
P C Adamson, S M Blaney, B C Widemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study
S M Blaney, M N Needle, A Gillespie, et al.
Cancer
|
August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumors
S M Blaney, P C Phillips, R J Packer, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial
S M Blaney, N L Seibel, M O'Brien, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2010
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates
P A Baxter, P A Thompson, L M McGuffey, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2004
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
P C Adamson, S M Blaney, B C Widemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study
S M Blaney, M N Needle, A Gillespie, et al.
Cancer
|
August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumors
S M Blaney, P C Phillips, R J Packer, et al.
Page
of 5